Glonghui, March 20, 丨 Colley Pharmaceutical-B (1672.HK) fell more than 8% to HK$2.7, with a total market value of HK$2.9 billion. On March 20, Hong Kong stock Geli Pharmaceutical-B released its fiscal year 2022 annual report. The company achieved operating income of 54.09 million yuan from January 1, 2022 to December 31, 2022, a year-on-year decrease of 29.64%. The net loss attributable to the parent company was 315 million yuan. The loss increased by 58.20% over the previous year, and the basic earnings per share was -0.29 yuan.
港股异动 | 歌礼制药-B跌超8% 2022全年亏损3.15亿元
Changes in Hong Kong stocks | Geli Pharmaceutical-B fell more than 8% and lost $315 million for the full year of 2022
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.